Table 1 Baseline characteristics of patients undergoing aortic valve replacement

Age (yr)

66 ± 15

70 ± 8

65 ± 5

62 ± 11

68 ± 10

64 ± 14

0.850

61 (57–77

73 (63–76

65 (64–66

59 (53–73

69 (68–71

67 (63–71

0.966

[50–85])

[60–78])

[57–71])

[50–75])

[53–81])

[42–79])

Male sex

2 (40%)

3 (60%)

1 (20%)

3 (60%)

2 (40%)

2 (40%)

0.950

Height (cm)

159 ± 8

157 ± 8

161 ± 9

162 ± 13

159 ± 13

157 ± 14

0.658

Weight (kg)

65.7 ± 12.5

55.3 ± 9.0

60.8 ± 13.2

66.8 ± 16.5

57.4 ± 10.3

56.3 ± 11.5

0.139

BMI (kg/m²)

25.8 ± 2.7

22.3 ± 2.4

23.3 ± 3.6

25.1 ± 3.2

22.6 ± 2.0

22.5 ± 2.0

0.786

BSA (m²)

1.7 ± 0.2

1.6 ± 0.2

1.6 ± 0.2

1.7 ± 0.3

1.6 ± 0.2

1.6 ± 0.2

0.428

Smoker

2 (40%)

1 (20%)

0 (0%)

1 (20%)

2 (40%)

2 (40%)

0.808

Baseline LV EF (%)

64 ± 5

59 ± 6

61 ± 10

59 ± 7

60 ± 7

65 ± 6

0.950

Baseline troponin I (ng/ml)

0.01 (0.01–0.03)

0.01 (0.01–0.03)

0.01 (0.01–0.11)

0.01 (0.01–0.05)

0.01 (0.01–0.06)

0.01 (0.01–0.02)

0.950

Baseline hematocrit (%)

39 ± 4

39 ± 7

36 ± 7

41 ± 6

39 ± 7

38 ± 3

0.938

Baseline eGFR (mL/min/1.73 m²)

78.9 ± 17.4

75.9 ± 33.8

77.9 ± 14.0

82.5 ± 22.9

87.6 ± 15.5

79.2 ± 13.2

0.850

Operation

0.956

 AVR only

2 (40%)

2 (40%)

3 (60%)

1 (20%)

1 (20%)

3 (60%)

 AVR + ascending aorta surgery

2 (40%)

2 (40%)

1 (20%)

2 (40%)

2 (40%)

1 (20%)

 AVR + mitral valve surgery or CABG

1 (20%)

1 (20%)

1 (20%)

2 (40%)

2 (40%)

1 (20%)